Nahaleh Naraqi honors Pharmacy Day with a special message!
August 27, 2024
Author:
Nexuspharma
Nahale Naraghi honors Pharmacy Day with a special message of gratitude, recognizing the essential role pharmacists play in advancing healthcare and supporting patient well-being
I
Nahale Naraghi honors National Doctors Day in Iran!
August 22, 2024
Author:
Nexuspharma
On this special occasion of National Doctors Day, which coincides with the birthday of the esteemed Persian scholar Avicenna, Nahaleh Naraghi, extends heartfelt gratitude to
Treatment and Reduction of Menopause Symptoms with New Drugs by “Atipharmed”
August 10, 2024
Author:
Nexuspharma
The pharmaceutical company “Atipharmed,” a subsidiary of the Actover Group, has introduced two new drugs to the national market, which are used for hormone
Visual Report on the Introduction of Actonib and Its application in Dermatology
July 31, 2024
Author:
Nexuspharma
Baricitinib is the first drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe stages of alopecia
Production of the first drug approved by FDA for the treatment of severe alopecia areata in Iran
July 31, 2024
Author:
Nexuspharma
Baricitinib, marketed under the brand name Actonib, is the first FDA-approved medication for the treatment of moderate to severe alopecia areata in adults. This
Neurostyle Launch Event
July 17, 2024
Author:
Nexuspharma
Dr. Roxana Kia, CEO of Nexus Pharmaceutical Company (subsidiary company of Actoverco) announced that Neurostyle, produced in tablet form by Nexus specialists, can be